Lepu Medical Technology (Beijing) Co., Ltd. (SHE: 300003)
China
· Delayed Price · Currency is CNY 9.47
0.00 (0.00%)
Sep 9, 2024, 1:51 PM CST
Lepu Medical Technology (Beijing) Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 7,004 | 7,916 | 10,553 | 10,613 | 7,992 | 7,759 | Upgrade
|
| Other Revenue | 58.48 | 64.24 | 56.93 | 46.74 | 46.61 | 36.29 | Upgrade
|
| Revenue | 7,062 | 7,980 | 10,609 | 10,660 | 8,039 | 7,796 | Upgrade
|
| Revenue Growth (YoY) | -26.26% | -24.78% | -0.47% | 32.61% | 3.12% | 22.64% | Upgrade
|
| Cost of Revenue | 2,680 | 2,982 | 4,021 | 4,166 | 2,660 | 2,171 | Upgrade
|
| Gross Profit | 4,382 | 4,998 | 6,588 | 6,494 | 5,378 | 5,624 | Upgrade
|
| Selling, General & Admin | 2,223 | 2,440 | 2,776 | 2,858 | 2,445 | 2,758 | Upgrade
|
| Research & Development | 794.35 | 879.42 | 957.06 | 907.94 | 736.13 | 543.91 | Upgrade
|
| Other Operating Expenses | 95.55 | 58.37 | 33.9 | 103.14 | 82.56 | 91.58 | Upgrade
|
| Operating Expenses | 3,148 | 3,404 | 3,793 | 3,882 | 3,303 | 3,427 | Upgrade
|
| Operating Income | 1,234 | 1,594 | 2,795 | 2,612 | 2,076 | 2,197 | Upgrade
|
| Interest Expense | -170.76 | -170.65 | -188.78 | -228.49 | -268.92 | -321.7 | Upgrade
|
| Interest & Investment Income | 110.73 | 115.34 | 87.99 | 57.59 | 43.16 | 239.41 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.15 | -25.38 | 16.14 | 6.58 | -26.96 | 6.82 | Upgrade
|
| Other Non Operating Income (Expenses) | -29.43 | -7.99 | -25.77 | -79.03 | -23.96 | -151.18 | Upgrade
|
| EBT Excluding Unusual Items | 1,144 | 1,505 | 2,684 | 2,368 | 1,799 | 1,970 | Upgrade
|
| Impairment of Goodwill | -33.45 | -33.45 | - | - | - | -108.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | -19.09 | -13.44 | -70.91 | -367.54 | 298.06 | 106.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.52 | -4.07 | 0.02 | 19.9 | 2.29 | 4.12 | Upgrade
|
| Asset Writedown | -25.6 | -6.93 | -1.72 | -2.39 | -16.99 | -36.87 | Upgrade
|
| Other Unusual Items | 132.33 | 107.31 | - | 127.71 | 121.03 | 127.17 | Upgrade
|
| Pretax Income | 1,205 | 1,554 | 2,612 | 2,146 | 2,203 | 2,063 | Upgrade
|
| Income Tax Expense | 220.33 | 262.15 | 365.73 | 365.73 | 326.23 | 339.46 | Upgrade
|
| Earnings From Continuing Operations | 984.35 | 1,292 | 2,246 | 1,780 | 1,877 | 1,724 | Upgrade
|
| Minority Interest in Earnings | 9.6 | -34.15 | -42.28 | -61.09 | -75.15 | 1.51 | Upgrade
|
| Net Income | 993.96 | 1,258 | 2,204 | 1,719 | 1,802 | 1,725 | Upgrade
|
| Net Income to Common | 993.96 | 1,258 | 2,204 | 1,719 | 1,802 | 1,725 | Upgrade
|
| Net Income Growth | -47.61% | -42.91% | 28.18% | -4.58% | 4.44% | 41.57% | Upgrade
|
| Shares Outstanding (Basic) | 1,857 | 1,862 | 1,802 | 1,792 | 1,777 | 1,770 | Upgrade
|
| Shares Outstanding (Diluted) | 1,857 | 1,862 | 1,817 | 1,808 | 1,777 | 1,770 | Upgrade
|
| Shares Change (YoY) | 0.34% | 2.48% | 0.50% | 1.75% | 0.37% | -0.64% | Upgrade
|
| EPS (Basic) | 0.54 | 0.68 | 1.22 | 0.96 | 1.01 | 0.97 | Upgrade
|
| EPS (Diluted) | 0.54 | 0.68 | 1.21 | 0.95 | 1.01 | 0.97 | Upgrade
|
| EPS Growth | -47.79% | -44.29% | 27.54% | -6.22% | 4.05% | 42.49% | Upgrade
|
| Free Cash Flow | 303.25 | 145.69 | 1,885 | 2,078 | 1,490 | 1,427 | Upgrade
|
| Free Cash Flow Per Share | 0.16 | 0.08 | 1.04 | 1.15 | 0.84 | 0.81 | Upgrade
|
| Dividend Per Share | 0.473 | 0.331 | 0.341 | 0.275 | 0.228 | 0.200 | Upgrade
|
| Dividend Growth | 38.83% | -2.81% | 24.00% | 20.61% | 14.00% | 21.21% | Upgrade
|
| Gross Margin | 62.05% | 62.63% | 62.10% | 60.92% | 66.90% | 72.15% | Upgrade
|
| Operating Margin | 17.47% | 19.97% | 26.34% | 24.50% | 25.82% | 28.18% | Upgrade
|
| Profit Margin | 14.07% | 15.77% | 20.77% | 16.13% | 22.42% | 22.13% | Upgrade
|
| Free Cash Flow Margin | 4.29% | 1.83% | 17.77% | 19.49% | 18.53% | 18.31% | Upgrade
|
| EBITDA | 1,691 | 2,040 | 3,205 | 3,004 | 2,464 | 2,481 | Upgrade
|
| EBITDA Margin | 23.95% | 25.57% | 30.21% | 28.18% | 30.65% | 31.83% | Upgrade
|
| D&A For EBITDA | 457.81 | 446.75 | 410.11 | 392.37 | 388.21 | 284.49 | Upgrade
|
| EBIT | 1,234 | 1,594 | 2,795 | 2,612 | 2,076 | 2,197 | Upgrade
|
| EBIT Margin | 17.47% | 19.97% | 26.34% | 24.50% | 25.82% | 28.18% | Upgrade
|
| Effective Tax Rate | 18.29% | 16.86% | 14.00% | 17.04% | 14.81% | 16.45% | Upgrade
|
| Revenue as Reported | 7,062 | 7,980 | 10,609 | 10,660 | 8,039 | 7,796 | Upgrade
|
| Advertising Expenses | - | 84.23 | 60.08 | 76.04 | 76.08 | 66.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.